CYABRA, INC.
CYABRA, INC. is a Delaware corporation formed as a wholly owned subsidiary of Trailblazer Holdings, Inc. for the sole purpose of entering into a business combination. It has no assets, operations or liabilities and currently has one officer. The proposed transaction would make Cyabra Strategy Ltd., a private company organized in Israel, a wholly owned subsidiary of CYABRA, INC., and rename the combined company Cyabra, Inc. CYABRA, INC. does not describe operating products, services, customers or sources of income. Its principal executive offices are in New York, New York.
No SEC Form 4 filings for $CYAB in the last 30 days.
See all $CYAB insider activity →Cyabra (NASDAQ:CYAB) secured a six-figure contract with a Southeast Asian government agency for its AI intelligence platform. The platform analyzes online information to identify security threats. The deal expands Cyabra's presence in the Asia-Pacific government sector, though financial details were not disclosed.
Cyabra, Inc. (NASDAQ: CYAB) formed a National Security Advisory Council chaired by former U.S. Secretary of State Michael Pompeo. The council will advise on federal procurement and countering synthetic media threats. Cyabra was recently selected for FBI and U.S. Special Operations Command contracts. The company provides AI-powered narrative intelligence services.
Cyabra (NASDAQ: CYAB) announced an enterprise agreement with a Fortune 500 media company to provide AI-powered narrative intelligence services. The platform will be used for audience authenticity evaluation, influence campaign tracking, and manipulated content detection. Financial terms were not disclosed, and this deal expands Cyabra's presence into the media and entertainment sector.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CYAB (CYABRA, INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent CYAB coverage spans financial news, corporate actions and market movers.
Contract award supports incremental revenue visibility and validates demand for Cyabra’s open-source intelligence and narrative monitoring platform in Asia-Pacific government use cases.
The advisory council signals strategic push into U.S. federal security markets, likely boosting investor interest.
The new contract expands Cyabra's addressable market and could lift revenue expectations.
The contract is expected to boost revenue and improve market sentiment.
The contract could provide new revenue streams and increase visibility in the federal market.
AlphAI scores every news story that mentions CYAB with an AI model for sentiment and relevance, and aggregates insider trades from CYABRA, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cyabra (NASDAQ:CYAB) secured a six-figure contract with a Southeast Asian government agency for its AI intelligence platform. The platform analyzes online information to identify security threats. The deal expands Cyabra's presence in the Asia-Pacific government sector, though financial details were not disclosed.
4 min readCyabra, Inc. (NASDAQ: CYAB) formed a National Security Advisory Council chaired by former U.S. Secretary of State Michael Pompeo. The council will advise on federal procurement and countering synthetic media threats. Cyabra was recently selected for FBI and U.S. Special Operations Command contracts. The company provides AI-powered narrative intelligence services.
2 min readCyabra (NASDAQ: CYAB) announced an enterprise agreement with a Fortune 500 media company to provide AI-powered narrative intelligence services. The platform will be used for audience authenticity evaluation, influence campaign tracking, and manipulated content detection. Financial terms were not disclosed, and this deal expands Cyabra's presence into the media and entertainment sector.
2 min readCyabra, Inc. (CYAB) secured a position on the FBI's Specialized OSINT Tools IDIQ, allowing task orders through 2031. Michael R. Pompeo joined the company's board as non-executive chairman. Cyabra is a Nasdaq-listed digital-risk intelligence firm.
1 min readCyabra (NASDAQ:CYAB) won a position under the FBI's contract for AI content analysis, covering image and video categories. The five-year contract allows Cyabra to compete for task orders from FBI divisions. The company's AI platform detects synthetic content and authenticity. Cyabra aims to expand its federal government services.
1 min readCyabra, Inc. (Nasdaq: CYAB) announced its subsidiary was awarded positions under the FBI's Specialized Open-Source Intelligence (OSINT) Tools contract. The five-year contract, running through 2031, allows Cyabra to compete for task orders related to AI-powered image and video analysis. The company's platform detects manipulated and synthetic content, addressing growing demand from federal agencies.
2 min readCyabra, Inc. (Nasdaq: CYAB) has joined the USSOCOM’s SOF RACER consortium, enabling it to compete for special operations technology requirements. The AI-powered platform detects coordinated manipulation and inauthentic activity, supporting government and defense customers. Cyabra's membership is part of its U.S. public sector expansion, with recent collaborations and hires.
1 min readCYABRA, INC. (CYAB) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities. As previously disclosed, on July 9, 2026, Cyabra, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Alpha Capital Anstalt (the “Holder”) that holds the outstanding Series C Convertible Prefer
2 min readCYABRA, INC. (CYAB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Adoption of an amendment to the 2026 Omnibus Equity Incentive Plan On September 2, 2026, Cyabra, Inc. (the “ Company ”) hel
1 min readU.S. stocks were mixed on Friday, with the Dow up 0.19% and the NASDAQ down 0.01%. The Chicago PMI fell to 47.1 in August, missing estimates. Quoin Pharmaceuticals (QNRX) rose 43% after positive clinical trial results and financing news. BioXcel Therapeutics (BTAI) dropped 73% after filing for bankruptcy.
2 min read
